Gain Therapeutics announces the appointment of Gene Mack, MBA as its CFO, effective as of April 8, 2024. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
- Gain Therapeutics appoints Jonas Hannestad as CMO
- Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
- Gain Therapeutics reports FY23 EPS ($1.71), consensus ($1.57)
- GANX Earnings this Week: How Will it Perform?
